OT You are switching the subject. We are talking about what the rational decision was post-panel. My contention is that it was to sell. In fact I sold about 75% of my holdings in DNDN at that time because I thought it went up too far without an FDA approval. Anybody that made real money on it this year did the same. So the allegation against Dew - that his advice re DNDN is worthless - is not correct. Despite this, I disagree w/him on RPRX. My gut tells me Joe P is not a crook. Back to our regular programming.
Market Data 
Markets
